Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Related Citations for PubMed (Select 9681527)

1.

Validation of a model predicting enrollment status in a chemoprevention trial for breast cancer.

Yeomans Kinney A, Vernon SW, Shui W, Weber DV, Schell M, Vogel VG.

Cancer Epidemiol Biomarkers Prev. 1998 Jul;7(7):591-5.

2.

Factors related to enrollment in the breast cancer prevention trial at a comprehensive cancer center during the first year of recruitment.

Yeomans-Kinney A, Vernon SW, Frankowski RF, Weber DM, Bitsura JM, Vogel VG.

Cancer. 1995 Jul 1;76(1):46-56.

PMID:
8630876
3.

The effect of physician recommendation on enrollment in the Breast Cancer Chemoprevention Trial.

Kinney AY, Richards C, Vernon SW, Vogel VG.

Prev Med. 1998 Sep-Oct;27(5 Pt 1):713-9.

PMID:
9808803
4.

Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users.

Rondanina G, Puntoni M, Severi G, Varricchio C, Zunino A, Feroce I, Bonanni B, Decensi A.

J Clin Oncol. 2008 Mar 20;26(9):1537-43. doi: 10.1200/JCO.2007.13.6739.

5.

Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.

Freedman AN, Graubard BI, Rao SR, McCaskill-Stevens W, Ballard-Barbash R, Gail MH.

J Natl Cancer Inst. 2003 Apr 2;95(7):526-32.

6.

Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.

Melnikow J, Paterniti D, Azari R, Kuenneth C, Birch S, Kuppermann M, Nuovo J, Keyzer J, Henderson S.

Cancer. 2005 May 15;103(10):1996-2005.

7.

Chemoprevention of breast cancer in the older patient.

Minton SE.

Hematol Oncol Clin North Am. 2000 Feb;14(1):113-30. Review.

PMID:
10680075
8.

Breast cancer risk in primary care: implications for chemoprevention.

Lewis CL, Kinsinger LS, Harris RP, Schwartz RJ.

Arch Intern Med. 2004 Sep 27;164(17):1897-903.

PMID:
15451765
9.

Barriers to minority participation in breast carcinoma prevention trials.

Grann VR, Jacobson JS, Troxel AB, Hershman D, Karp J, Myers C, Neugut AI.

Cancer. 2005 Jul 15;104(2):374-9.

10.

Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force.

Kinsinger LS, Harris R, Woolf SH, Sox HC, Lohr KN.

Ann Intern Med. 2002 Jul 2;137(1):59-69. Review.

PMID:
12093250
11.

Chemoprevention of breast cancer: implications for postmenopausal women.

Fabian CJ, Kimler BF.

Drugs Aging. 2002;19(1):43-78. Review.

PMID:
11929326
12.

From adjuvant therapy to breast cancer prevention: BCPT and STAR.

Dunn BK, Ford LG.

Breast J. 2001 May-Jun;7(3):144-57. Review.

PMID:
11469927
13.

The impact of socioeconomic status and race on trial participation for older women with breast cancer.

Gross CP, Filardo G, Mayne ST, Krumholz HM.

Cancer. 2005 Feb 1;103(3):483-91.

14.

Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.

Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA.

J Natl Cancer Inst. 2001 Mar 7;93(5):358-66.

15.

Women's interest in chemoprevention for breast cancer.

Bastian LA, Lipkus IM, Kuchibhatla MN, Weng HH, Halabi S, Ryan PD, Skinner CS, Rimer BK.

Arch Intern Med. 2001 Jul 9;161(13):1639-44.

PMID:
11434796
16.

Decision analysis of tamoxifen for the prevention of invasive breast cancer.

Grann VR, Sundararajan V, Jacobson JS, Whang W, Heitjan DF, Antman KH, Neugut AI.

Cancer J. 2000 May-Jun;6(3):169-78.

PMID:
10882333
17.

Chemoprevention: drug pricing and mortality: the case of tamoxifen.

Melnikow J, Kuenneth C, Helms LJ, Barnato A, Kuppermann M, Birch S, Nuovo J.

Cancer. 2006 Sep 1;107(5):950-8.

18.

The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials.

Martino S, Costantino J, McNabb M, Mershon J, Bryant K, Powles T, Secrest RJ.

Oncologist. 2004;9(2):116-25. Review.

19.

Breast cancer risks and prevention: implications of the Breast Cancer Prevention Trial results.

Crowell EB Jr, Jubelirer SJ.

W V Med J. 2000 Nov-Dec;96(6):598-601.

PMID:
11194088
20.

Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.

Vogel VG.

Clin Cancer Res. 2001 Dec;7(12 Suppl):4413s-4418s; discussion 4411s-4412s. Review.

PMID:
11916233
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk